85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05041426 (ClinicalTrials.gov)	December 6, 2021	20/4/2021	Letermovir for CMV Prevention After Lung Transplantation	An Open-label Pilot Protocol to Evaluate the Efficacy of Letermovir for the Prevention of Human Cyto ...	Lung Transplant;CMV	Drug: Letermovir;Drug: Valganciclovir	Fernanda P Silveira, MD, MS	Merck Sharp & Dohme LLC	Recruiting	18 Years	100 Years	All	30	Phase 2	United States
2	NCT02871401 (ClinicalTrials.gov)	January 3, 2018	15/8/2016	A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)	A Phase One-B (1B) Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)	Idiopathic Pulmonary Fibrosis	Drug: Valganciclovir;Drug: Placebo	Vanderbilt University Medical Center	Genentech, Inc.	Completed	21 Years	80 Years	All	31	Phase 1	United States

First Previous1Next Last